Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Accuracy of 18F-Fluorocholine PET/MRI and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

NCT07444723 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

NCT NCT07444723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07444723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Accuracy of 18F-Fluorocholine PET/MRI and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase
Phase 2/3
Overall status
Recruiting
Start date
April 16, 2026
Completion date
February 5, 2036
Enrollment
193 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heritable hyperparathyroidism, hyperparathyroid-jaw tumor syndrome, multiple endocrine neoplasias, parathyroid cancer, primary hyperparathyroidism